In vitro and in vivo magnetofection™: A move towards gene therapy;Magnétofection™ in vitro et in vivo : Une voie vers la thérapie génique

Annales de Biologie Clinique

Volumn 68, Issue 2, 2010, Pages 133-142

  Sapet, Cédric ^a   Laurent, Nicolas ^a   Gourrierec, Loïc Le ^a   Augier, Séverine ^a   Zelphati, Olivier ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Gene therapy; Magnetic nanoparticles; Magnetofection; Nucleic acid delivery; Transduction; Transfection

Indexed keywords

DNA; NANOPARTICLE;

ARTICLE; GENE THERAPY; GENETIC DISORDER; GENETIC TRANSFECTION; GENETICS; HUMAN; MAGNETISM; METHODOLOGY; PLASMID; VIRUS;

DNA; GENE THERAPY; GENETIC DISEASES, INBORN; HUMANS; MAGNETICS; NANOPARTICLES; PLASMIDS; TRANSFECTION; VIRUSES;

EID: 77950336912     PISSN: 00033898     EISSN: 19506112     Source Type: Journal    
DOI: 10.1684/abc.2010.0417     Document Type: Article

References (58)

1. Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, Gross F, Yvon E, Nusbaum P, et al. Gene therapy of human severe combined immunodeficiency (SCID) -X1 disease. Science 2000;288:669-72.
2. Website : http://www.wiley.co.uk/genetherapy/clinical/. John Wiley and Sons 2007.
3. Mehier-Humbert S, Guy RH. Physical methods for gene transfer : improving the kinetics of gene delivery into cells. Adv Drug Deliv Rev 2005;57:733-53.
4. Kostarelos K, Miller AD. What role can chemistry play in cationic liposome-based gene therapy research today ? Adv Genet 2005 ; 53 PA : 69-118.
5. Li W, Szoka Jr FC. Lipid-based nanoparticles for nucleic acid delivery. Pharm Res 2007;24:438-49.
6. Mintzer MA, Simanek EE. Nonviral vectors for gene delivery. Chem Rev 2009;109:259-302.
7. Plank C, Anton M, Rudolph C, Rosenecker J, Krotz F. Enhancing and targeting nucleic acid delivery by magnetic force. Expert Opin Biol Ther 2003;3:745-58.
8. Schillinger U, Brill T, Rudolph C, Huth S, Gersting S, Krotz F, et al. Advances in magnetofection-magnetically guided nucleic acid delivery. J Magn Mag Mater 2005;293:501-8.
9. Mykhaylyk O, Antequera YS, Vlaskou D, Plank C. Generation of magnetic nonviral gene transfer agents and magnetofection in vitro. Nat Protoc 2007;2:2391-411.
10. Scherer F, Anton M, Schillinger U, Henke J, Bergemann C, Kruger A, et al. Magnetofection : enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Ther 2002;9:102-9.
11. Plank C, Schillinger U, Scherer F, Bergemann C, Remy JS, Krotz F, et al. The magnetofection method : using magnetic force to enhance gene delivery. Biol Chem 2003;384:737-47.
12. Sauer AM, de Bruin KG, Ruthardt N, Mykhaylyk O, Plank C, Brauchle C. Dynamics of magnetic lipoplexes studied by single particle tracking in living cells. J Control Release 2009;137:136-45.
13. Khalil IA, Kogure K, Akita H, Harashima H. Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery. Pharmacol Rev 2006;58:32-45.
14. Boussif O, Lezoualc'h F, Zanta MA, Mergny MD, Scherman D, Demeneix B, et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA 1995;92:7297-301.
15. Farhood H, Serbina N, Huang L. The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer. Biochim Biophys Acta 1995;1235:289-95.
16. Zelphati O, Szoka Jr FC. Mechanism of oligonucleotide release from cationic liposomes. Proc Natl Acad Sci USA 1996;93:11493-8.
17. Melchior F, Gerace L. Mechanisms of nuclear protein import. Curr Opin Cell Biol 1995;7:310-8.
18. Satoh K, Iwata A, Murata M, Hikata M, Hayakawa T, Yamaguchi T. Virus concentration using polyethyleneimine-conjugated magnetic beads for improving the sensitivity of nucleic acid amplification tests. J Virol Methods 2003;114:11-9.
19. Sacha JB, Reynolds MR, Buechler MB, Chung C, Jonas AK, Wallace LT, et al. Differential antigen presentation kinetics of CD8+ T-cell epitopes derived from the same viral protein. J Virol 2008;82:9293-8.
20. Sacha JB, Chung C, Rakasz EG, Spencer SP, Jonas AK, Bean AT, et al. Gag-specific CD8+ T lymphocytes recognize infected cells before AIDS-virus integration and viral protein expression. J Immunol 2007;178:2746-54.
21. Morishita N, Nakagami H, Morishita R, Takeda S, Mishima F, Terazono B, et al. Magnetic nanoparticles with surface modification enhanced gene delivery of HVJ-E vector. Biochem Biophys Res Commun 2005;334:1121-6.
22. Orlando C, Copreni E, Mykhaylyk O, Castellani S, Zelphati O, Plank C, et al. Facilitation of lentiviral-mediated transduction of airway epithelial cells by magnetofection. J Cystic Fibrosis 2008;7:S22.
23. Kadota S, Kanayama T, Miyajima N, Takeuchi K, Nagata K. Enhancing of measles virus infection by magnetofection. J Virol Methods 2005;128:61-6.
24. Steele IA, Dimaline R, Pritchard DM, Peek Jr RM, Wang TC, Dockray GJ, et al. Helicobacter and gastrin stimulate Reg1 expression in gastric epithelial cells through distinct promoter elements. Am J Physiol Gastrointest Liver Physiol 2007;293:G347-G354.
25. Nagata D, Takahashi M, Sawai K, Tagami T, Usui T, Shimatsu A, et al. Molecular mechanism of the inhibitory effect of aldosterone on endothelial NO synthase activity. Hypertension 2006;48:165-71.
26. Sbai O, Ferhat L, Bernard A, Gueye Y, Ould-Yahoui A, Thiolloy S, et al. Vesicular trafficking and secretion of matrix metalloproteinases-2, -9 and tissue inhibitor of metalloproteinases-1 in neuronal cells. Mol Cell Neurosci 2008;39:549-68.
27. Couchoux H, Allard B, Legrand C, Jacquemond V, Berthier C. Loss of caveolin-3 induced by the dystrophy-associated P104L mutation impairs L-type calcium channel function in mouse skeletal muscle cells. J Physiol 2007;580:745-54.
28. Megias J, Guillen MI, Clerigues V, Rojo AI, Cuadrado A, Castejon MA, et al. Heme oxygenase-1 induction modulates microsomal prostaglandin E synthase-1 expression and prostaglandin E (2) production in osteoarthritic chondrocytes. Biochem Pharmacol 2009;77:1806-13.
29. Lee CH, Kim EY, Jeon K, Tae JC, Lee KS, Kim YO, et al. Simple, efficient, and reproducible gene transfection of mouse embryonic stem cells by magnetofection. Stem Cells Dev 2008;17:133-41.
30. Ivanov A, Esclapez M, Pellegrino C, Shirao T, Ferhat L. Drebrin A regulates dendritic spine plasticity and synaptic function in mature cultured hippocampal neurons. J Cell Sci 2009;122:524-34.
31. Buerli T, Pellegrino C, Baer K, Lardi-Studler B, Chudotvorova I, Fritschy JM, et al. Efficient transfection of DNA or shRNA vectors into neurons using magnetofection. Nat Protoc 2007;2:3090-101.
32. Guzman-Beltran S, Espada S, Orozco-Ibarra M, Pedraza-Chaverri J, Cuadrado A. Nordihydroguaiaretic acid activates the antioxidant pathway Nrf2/HO-1 and protects cerebellar granule neurons against oxidative stress. Neurosci Lett 2008;447:167-71.
33. Uchida Y, Ohshima T, Sasaki Y, Suzuki H, Yanai S, Yamashita N, et al. Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3beta phosphorylation of CRMP2 : implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease. Genes Cells 2005;10:165-79.
34. De Lartigue G, Dimaline R, Varro A, Dockray GJ. Cocaine-and amphetamine-regulated transcript : stimulation of expression in rat vagal afferent neurons by cholecystokinin and suppression by ghrelin. J Neurosci 2007;27:2876-82.
35. Burdyga G, de Lartigue G, Raybould HE, Morris R, Dimaline R, Varro A, et al. Cholecystokinin regulates expression of Y2 receptors in vagal afferent neurons serving the stomach. J Neurosci 2008;28:11583-92.
36. McCaig C, Duval C, Hemers E, Steele I, Pritchard DM, Przemeck S, et al. The role of matrix metalloproteinase-7 in redefining the gastric microenvironment in response to Helicobacter pylori. Gastroenterology 2006;130:1754-63.
37. Deleuze V, Chalhoub E, El-Hajj R, Dohet C, Le Clech M, Couraud PO, et al. TAL-1/SCL and its partners E47 and LMO2 up-regulate VE-cadherin expression in endothelial cells. Mol Cell Biol 2007;27:2687-97.
38. Sapet C, Simoncini S, Loriod B, Puthier D, Sampol J, Nguyen C, et al. Thrombin-induced endothelial microparticle generation : identification of a novel pathway involving ROCK-II activation by caspase-2. Blood 2006;108:1868-76.
39. Mykhaylyk O, Zelphati O, Rosenecker J, Plank C. siRNA delivery by magnetofection. Curr Opin Mol Ther 2008;10:493-505.
40. Mykhaylyk O, Zelphati O, Hammerschmid E, Anton M, Rosenecker J, Plank C. Recent advances in magnetofection and its potential to deliver siRNAs in vitro. Methods Mol Biol 2009;487:111-46.
41. Krotz F, de Wit C, Sohn HY, Zahler S, Gloe T, Pohl U, et al. Magnetofection-a highly efficient tool for antisense oligonucleotide delivery in vitro and in vivo. Mol Ther 2003;7:700-10.
42. Mannell H, Hellwig N, Gloe T, Plank C, Sohn HY, Groesser L, et al. Inhibition of the tyrosine phosphatase SHP-2 suppresses angiogenesis in vitro and in vivo. J Vasc Res 2008;45:153-63.
43. Gilchrist RK, Medal R, Shorey WD, Hanselman RC, Parrott JC, Taylor CB. Selective inductive heating of lymph nodes. Ann Surg 1957;146:596-606.
44. Lubbe AS, Bergemann C, Huhnt W, Fricke T, Riess H, Brock JW, et al. Preclinical experiences with magnetic drug targeting : tolerance and efficacy. Cancer Res 1996;56:4694-701.
45. Koda J, Venook A, Walser E. Phase I/II trial of hepatic intraarterial delivery of doxorubicin hydrochloride adsorbed to magnetic targeted carriers in patients with hepatocarcinoma. Eur J Cancer 2002;38:S18.
46. Widder KJ, Marino PA, Morris RM, Howard DP, Poore GA, Senyei AE. Selective targeting of magnetic albumin microspheres to the Yoshida sarcoma : ultrastructural evaluation of microsphere disposition. Eur J Cancer Clin Oncol 1983;19:141-7.
47. Wilson MW, Kerlan Jr RK, Fidelman NA, Venook AP, LaBerge JM, Koda J, et al. Hepatocellular carcinoma : regional therapy with a magnetic targeted carrier bound to doxorubicin in a dual MR imaging/conventional angiography suite-initial experience with four patients. Radiology 2004;230:287-93.
48. Holzbach T, Vlaskou D, Neshkova I, Konerding MA, Wortler K, Mykhaylyk O, et al. Non-viral VEGF gene therapy - Magnetofection of acoustically active magnetic lipospheres ("Magnetobubbles") increases tissue-survival in an oversized skin flap model. J Cell Mol Med 2008 (Nov) : 14 Epub ahead of print.
49. Svingen T, Wilhelm D, Combes AN, Hosking B, Harley VR, Sinclair AH, et al. Ex vivo magnetofection : a novel strategy for the study of gene function in mouse organogenesis. Dev Dyn 2009;238:956-64.
50. Jahnke A, Hirschberger J, Fischer C, Brill T, Kostlin R, Plank C, et al. Intra-tumoral gene delivery of feIL-2, feIFN-gamma and feGM-CSF using magnetofection as a neoadjuvant treatment option for feline fibrosarcomas : a phase-I study. J Vet Med A Physiol Pathol Clin Med 2007;54:599-606.
51. Huttinger C, Hirschberger J, Jahnke A, Kostlin R, Brill T, Plank C, et al. Neoadjuvant gene delivery of feline granulocyte-macrophage colony-stimulating factor using magnetofection for the treatment of feline fibrosarcomas : a phase I trial. J Gene Med 2008;10:655-67.
52. Niidome T, Huang L. Gene therapy progress and prospects : nonviral vectors. Gene Ther 2002;9:1647-52.
53. Dames P, Gleich B, Flemmer A, Hajek K, Seidl N, Wiekhorst F, et al. Targeted delivery of magnetic aerosol droplets to the lung. Nat Nanotechnol 2007;2:495-9.
54. Foust KD, Nurre E, Montgomery CL, Hernandez A, Chan CM, Kaspar BK. Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat Biotechnol 2009;27:59-65.
55. Ackman JB, Aniksztejn L, Crepel V, Becq H, Pellegrino C, Cardoso C, et al. Abnormal network activity in a targeted genetic model of human double cortex. J Neurosci 2009;29:313-27.
56. Burdorf L, Schuhmann N, Postrach J, Thein E, Hallek M, Reichart B, et al. AAV-mediated gene transfer to cardiac cells in a heterotopic rat heart transplantation model. Transplant Proc 2007;39:567-8.
57. Hofmann A, Wenzel D, Becher UM, Freitag DF, Klein AM, Eberbeck D, et al. Combined targeting of lentiviral vectors and positioning of transduced cells by magnetic nanoparticles. Proc Natl Acad Sci USA 2009;106:44-9.
58. Xenariou S, Griesenbach U, Ferrari S, Dean P, Scheule RK, Cheng SH, et al. Using magnetic forces to enhance non-viral gene transfer to airway epithelium in vivo. Gene Ther 2006;13:1545-52.